Fullerton Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fullerton Fund Management's BMY Position: Q3 2026 in Review
Fullerton Fund Management sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 12,607 shares — an estimated $726K sold.
Fullerton Fund Management first reported a position in BMY in Q3 2020 and held it in 7 quarters. The position peaked at $726K in Q2 2026. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Fullerton Fund Management reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Fullerton Fund Management sold 12,607 Bristol-Myers Squibb shares in Q3 2026, an estimated $726K.
- Fullerton Fund Management first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 7 quarters.
- Fullerton Fund Management's Bristol-Myers Squibb position peaked at $726K in Q2 2026.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Fullerton Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.